Publications by authors named "Jian-Kang Yu"

Article Synopsis
  • - The standard treatment for small-cell lung cancer (SCLC) is platinum-based chemotherapy, which has a high response rate of 50-90%.
  • - Durvalumab, an immune checkpoint inhibitor, is now recommended as a first-line treatment alongside traditional chemotherapy for advanced SCLC, although it can lead to immune-related side effects.
  • - This case report highlights a man in his late 50s with extensive-stage SCLC who developed rare and potentially fatal autoimmune encephalitis after receiving durvalumab treatment, contributing to the understanding of this adverse effect.
View Article and Find Full Text PDF

In the present study, an attempt is made to reveal the main mechanism of photodissociation on the lowest-lying Rydberg state (1)B(1) of ketene, referred to as the second singlet excited state S(2), by means of the complete active space self-consistent field and the second-order multiconfigurational perturbation theory methods. The located S(2)S(1)T(1) three-surface intersection plays an important role in the dissociation process. It is shown that the intersection permits an efficient internal conversion from S(2) to S(1) state, but prohibits the intersystem crossing from S(2) to T(1) state because of the small spin-orbital coupling value of 0.

View Article and Find Full Text PDF

The structures and isomerization of Si(2)CN species are explored at density functional theory and ab initio levels. Fourteen minimum isomers are located connected by 23 interconversion transition states. At the coupled-cluster single double (CCSD)(T)/6-311+G(2df)//QCISD/6-311G(d) +zero-point vibrational energies level, the thermodynamically most stable isomer is a four-membered ring form cSiSiCN 1 with Si-C cross bonding.

View Article and Find Full Text PDF